Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Status of Claims
This action is in reply to the amendments filed on 12/15/2025.
Claims 1-5 were amended. Claims 6-8 were canceled. Claims 9-12 were newly added.
Claims 1-5 and 9-12 are currently pending and have been examined.
Claim Rejections - 35 USC § 101
35 U.S.C. 101 reads as follows:
Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title.
Claims 1-5 and 9-12 are rejected under 35 U.S.C. 101 because the claimed invention is directed to an abstract idea without significantly more.
Claims 1-5 and 9-12: Step 2A Prong One
Claim 1 recites recording patient numerical responses to an Owestry Low Back Pain Disability Questionnaire (ODI), recording patient numerical responses to a Fear Avoidance Belief Questionnaire (FABQ), recording patient numerical responses to a Central Sensitization Inventory (CSI), scoring patient responses to a Pittsburgh Sleep Quality Index (PSI) questionnaire administered to the patient, outfitting a patient with an EMG sensor, and performing an objective movement assessment (OMA) on the patient using the EMG sensor, wherein the OMA includes cuing the patient to activate muscles in each of five myofascial lines that support the patient’s lumbopelvic region and on a condition that the patient has scored above a first predetermined threshold on the ODI, has scored above at least one respective predetermined threshold on at least one of the FABQ, CSI and PSI, and has successfully completed the OMA, assigning the patient to a first treatment protocol that comprises performing physical therapy, applying pain neuroscience education and applying biofeedback using the EMG.
Claim 4 recites recording patient numerical responses to an Owestry Low Back Pain Disability Questionnaire (ODI), recording patient numerical responses to a Fear Avoidance Belief Questionnaire (FABQ), recording patient numerical responses to a Central Sensitization Inventory (CSI), scoring patient responses to a Pittsburgh Sleep Quality Index (PSI) questionnaire administered to the patient, outfitting a patient with an EMG sensor, and performing an objective movement assessment (OMA) on the patient using the EMG sensor, wherein the OMA includes cuing the patient to activate muscles in each of five myofascial lines that support the patient’s lumbopelvic region and on a condition that the patient has scored above a first predetermined threshold on the ODI, has scored above at least one respective predetermined threshold on at least one of the FABQ, CSI and PSI, and has not successfully completed the OMA, assigning the patient to a treatment protocol that comprises performing progressive muscle relaxation, applying pain neuroscience education and applying biofeedback using the EMG.
Claim 5 recites recording patient numerical responses to an Owestry Low Back Pain Disability Questionnaire (ODI), recording patient numerical responses to a Fear Avoidance Belief Questionnaire (FABQ), recording patient numerical responses to a Central Sensitization Inventory (CSI), scoring patient responses to a Pittsburgh Sleep Quality Index (PSI) questionnaire administered to the patient, outfitting a patient with an EMG sensor, and performing an objective movement assessment (OMA) on the patient using the EMG sensor, wherein the OMA includes cuing the patient to activate muscles in each of five myofascial lines that support the patient’s lumbopelvic region and on a condition that the patient has scored below a first predetermined threshold on the ODI, has scored below respective predetermined thresholds on all of the FABQ, CSI and PSI, and has successfully completed the OMA, assigning the patient to a treatment protocol that comprises physical therapy and applying biofeedback using the EMG.
These limitations, as drafted, given the broadest reasonable interpretation, cover manual, human performance of the limitations, following rules or instructions, which constitutes Certain Methods of Organizing Human activity but for the recitation of generic computer components. That is, other than reciting “outfitting a patient with an EMG sensor,” and “applying biofeedback using the EMG,” nothing in the claim precludes the limitations from practically being performed by a human following rules or instructions or in the mind of a user. For example, but for the recited generic computer components, the claimed steps encompass a user recording patient numerical responses to an Owestry Low Back Pain Disability Questionnaire (ODI), recording patient numerical responses to a Fear Avoidance Belief Questionnaire (FABQ), recording patient numerical responses to a Central Sensitization Inventory (CSI), scoring patient responses to a Pittsburgh Sleep Quality Index (PSI) questionnaire administered to the patient, and performing an objective movement assessment (OMA) on the patient using the EMG sensor, wherein the OMA includes cuing the patient to activate muscles in each of five myofascial lines that support the patient’s lumbopelvic region and on a condition that the patient has scored above a first predetermined threshold on the ODI, has scored above at least one respective predetermined threshold on at least one of the FABQ, CSI and PSI, and has successfully completed the OMA, assigning the patient to a first treatment protocol that comprises performing physical therapy, and applying pain neuroscience. Claims 4 and 5 recite similar limitations with slight variations. If a claim limitation, under its broadest reasonable interpretation, covers manual, human performance of the limitation but for the recitation of generic computer components, then it falls within the Certain Methods of Organizing Human Activity grouping of abstract ideas. Accordingly, these claims recite an abstract idea.
Claims 2-3 and 9-12 incorporate the abstract idea identified above and recite additional limitations that expand on the abstract idea, but for the recitation of generic computer components, by reciting various combinations of recording patient numerical responses, the OMA, assigning the patient, and assessing body movements. Therefore, these claims are similarly drawn to Certain Methods of Organizing Human Activity.
Claims 1-5 and 9-12: Step 2A Prong Two
This judicial exception is not integrated into a practical application because the claims do not appear to recite any hardware for performing the method steps, but rather the method steps are being performed by a person or human being (as further recited in the preamble of the independent claims 1, 4 and 5 (“A method performed by a person”). On dependent claim 2, the remaining elements (“wide area network”) amount to no more than general purpose computer components being used by a clinician/human being (to perform the method step of evaluating the patient), with generally linking the abstract idea to a particular technological environment. As set forth in the 2019 Eligibility Guidance, 84 Fed. Reg. at 55 “merely include[ing] instructions to implement an abstract idea on a computer” is an example of when an abstract idea has not been integrated into a practical application.
Claims 1-5 and 9-12: Step 2B
The claim(s) does/do not include additional elements that are sufficient to amount to significantly more than the judicial exception because as discussed above with respect to integration into a practical application, the additional elements (usage of EMG sensor and applying biofeedback using EMG) are recited at a high level of generality, and merely utilized as tools to implement the abstract idea, as shown in Applicant’s specification, in Paragraph [0010], which discloses “In an aspect of the invention, an evidence driven protocol for CLBP is used in conjunction with a portable and wearable surface EMG sensor device paired with digital biofeedback software application pre-installed on a tablet computer”. Using generic computer components to perform abstract ideas does not provide a necessary inventive concept. See Alice, 573 U.S. at 223 (“mere recitation of a generic computer cannot transform a patent-ineligible abstract idea into a patent-eligible invention.”).
Gathering and analyzing information using conventional techniques and displaying the result has also been found to be insufficient to show an improvement to technology, (see MPEP 2106.05(a) and TLI Communications, 823 F.3d at 612-13, 118 USPQ2d at 1747-48).
Thus these elements taken individually or together do not amount to significantly more than the abstract ideas themselves.
Response To Arguments
Applicant’s arguments from the response filed on 12/15/2025 have been fully considered but they are not persuasive. Applicant’s arguments will be addressed below in the order in which they appeared.
In the remarks, Applicant asserts that (1) Regarding amended limitations of independent claims 1, 4 and 5, the claims are not directed to an abstract idea, but towards an improvement in a medical therapeutic procedure that cannot be performed by the human mind, in particular, “outfitting a patient with an EMG sensor performing an objective movement assessment (OMA) on the patient using the EMG sensor, wherein the OMA includes cuing the patient to activate muscles in each of five myofascial lines that support the patient’s lumbopelvic region” and “applying biofeedback using the EMG”.
In response to applicant’s arguments (1) as listed above, the examiner respectfully disagrees. Applicant’s arguments pertain to newly amended limitations, and have been addressed in the rejections above. As such, Applicant’s arguments have been considered but are not found to be persuasive.
Conclusion
Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a).
A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any extension fee pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the date of this final action.
Any inquiry concerning this communication or earlier communications from the examiner should be directed to Joy Chng whose telephone number is 571.270.7897. The examiner can normally be reached on Monday-Thursday and every other Friday.
If attempts to reach the examiner by telephone are unsuccessful, the examiner's supervisor, JASON DUNHAM can be reached on 571.272.8109. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866.217.9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/Joy Chng/
Primary Examiner, Art Unit 3686